Statistics
Publications
1
Citations
23
H-Index
1
Active since
2022
Affiliations
Yueqiang Wang is an author at Huazhong University of Science and Technology specializing in egfr inhibition, erlotinib therapy, and tyrosine kinase inhibitor therapy.
Publications per year
2022–2022
1
1
Defining the sensitivity landscape of EGFR variants to tyrosine kinase inhibitors
Lei An, Yueqiang Wang, Guangyao Wu et al. · Translational research · 2022 · 23 citations
Medicine, Cancer Biology, Oncology +14
1–1 of 1